Clinical Trial Update: Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating combination bortezomib-containing regimens in newly diagnosed t(4;14) positive multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• bortezomib-containing regimens (bortezomib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED